These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 19165203)

  • 21. Hypoxia inducible carbonic anhydrase IX, marker of tumour hypoxia, survival pathway and therapy target.
    Potter C; Harris AL
    Cell Cycle; 2004 Feb; 3(2):164-7. PubMed ID: 14712082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The basal-like breast carcinoma phenotype is regulated by SLUG gene expression.
    Storci G; Sansone P; Trere D; Tavolari S; Taffurelli M; Ceccarelli C; Guarnieri T; Paterini P; Pariali M; Montanaro L; Santini D; Chieco P; Bonafé M
    J Pathol; 2008 Jan; 214(1):25-37. PubMed ID: 17973239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxia and metabolic phenotypes during breast carcinogenesis: expression of HIF-1alpha, GLUT1, and CAIX.
    Chen CL; Chu JS; Su WC; Huang SC; Lee WY
    Virchows Arch; 2010 Jul; 457(1):53-61. PubMed ID: 20526721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic relevance of carbonic anhydrase IX expression is distinct in various subtypes of breast cancer and its silencing suppresses self-renewal capacity of breast cancer cells.
    Ivanova L; Zandberga E; Siliņa K; Kalniņa Z; Ābols A; Endzeliņš E; Vendina I; Romanchikova N; Hegmane A; Trapencieris P; Eglītis J; Linē A
    Cancer Chemother Pharmacol; 2015 Feb; 75(2):235-46. PubMed ID: 25422154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibrotic focus and hypoxia in male breast cancer.
    Kornegoor R; Verschuur-Maes AH; Buerger H; Hogenes MC; de Bruin PC; Oudejans JJ; Hinrichs B; van Diest PJ
    Mod Pathol; 2012 Oct; 25(10):1397-404. PubMed ID: 22684218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subcellular FIH-1 expression patterns in invasive breast cancer in relation to HIF-1α expression.
    Hyseni A; van der Groep P; van der Wall E; van Diest PJ
    Cell Oncol (Dordr); 2011 Dec; 34(6):565-70. PubMed ID: 21732131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
    Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S
    Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p300 and p53 levels determine activation of HIF-1 downstream targets in invasive breast cancer.
    Vleugel MM; Shvarts D; van der Wall E; van Diest PJ
    Hum Pathol; 2006 Aug; 37(8):1085-92. PubMed ID: 16867872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA damage is a prerequisite for p53-mediated proteasomal degradation of HIF-1alpha in hypoxic cells and downregulation of the hypoxia marker carbonic anhydrase IX.
    Kaluzová M; Kaluz S; Lerman MI; Stanbridge EJ
    Mol Cell Biol; 2004 Jul; 24(13):5757-66. PubMed ID: 15199132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbonic anhydrase IX is a marker of hypoxia and correlates with higher Gleason scores and ISUP grading in prostate cancer.
    Ambrosio MR; Di Serio C; Danza G; Rocca BJ; Ginori A; Prudovsky I; Marchionni N; Del Vecchio MT; Tarantini F
    Diagn Pathol; 2016 May; 11(1):45. PubMed ID: 27225200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4.
    Rademakers SE; Lok J; van der Kogel AJ; Bussink J; Kaanders JH
    BMC Cancer; 2011 May; 11():167. PubMed ID: 21569415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of the hypoxia pathway in breast cancer tissue and patient survival are inversely associated with tumor ascorbate levels.
    Campbell EJ; Dachs GU; Morrin HR; Davey VC; Robinson BA; Vissers MCM
    BMC Cancer; 2019 Apr; 19(1):307. PubMed ID: 30943919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The expression of metabolism-related proteins in phyllodes tumors.
    Kwon JE; Jung WH; Koo JS
    Tumour Biol; 2013 Feb; 34(1):115-24. PubMed ID: 22986897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of carbonic anhydrase and HIF-1α in Wilms tumours.
    Dungwa JV; Hunt LP; Ramani P
    BMC Cancer; 2011 Sep; 11():390. PubMed ID: 21910893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of hypoxia-related tissue factors in astrocytic gliomas. A multivariate survival study with emphasis upon carbonic anhydrase IX.
    Korkolopoulou P; Perdiki M; Thymara I; Boviatsis E; Agrogiannis G; Kotsiakis X; Angelidakis D; Rologis D; Diamantopoulou K; Thomas-Tsagli E; Kaklamanis L; Gatter K; Patsouris E
    Hum Pathol; 2007 Apr; 38(4):629-38. PubMed ID: 17367605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prognostic impact of a combined carbonic anhydrase IX and Ki67 signature in oral squamous cell carcinoma.
    Klimowicz AC; Bose P; Petrillo SK; Magliocco AM; Dort JC; Brockton NT
    Br J Cancer; 2013 Oct; 109(7):1859-66. PubMed ID: 24008660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer.
    Vleugel MM; Greijer AE; Shvarts A; van der Groep P; van Berkel M; Aarbodem Y; van Tinteren H; Harris AL; van Diest PJ; van der Wall E
    J Clin Pathol; 2005 Feb; 58(2):172-7. PubMed ID: 15677538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification.
    Betof AS; Rabbani ZN; Hardee ME; Kim SJ; Broadwater G; Bentley RC; Snyder SA; Vujaskovic Z; Oosterwijk E; Harris LN; Horton JK; Dewhirst MW; Blackwell KL
    Br J Cancer; 2012 Feb; 106(5):916-22. PubMed ID: 22333602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression.
    Pinheiro C; Sousa B; Albergaria A; Paredes J; Dufloth R; Vieira D; Schmitt F; Baltazar F
    Histol Histopathol; 2011 Oct; 26(10):1279-86. PubMed ID: 21870331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of HIF1α and CAXI predicts poor outcome in early-stage triple negative breast cancer.
    Jin MS; Lee H; Park IA; Chung YR; Im SA; Lee KH; Moon HG; Han W; Kim K; Kim TY; Noh DY; Ryu HS
    Virchows Arch; 2016 Aug; 469(2):183-90. PubMed ID: 27184798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.